104 related articles for article (PubMed ID: 1740372)
1. Hyperthermia reduces the occurrence of proliferative vitreoretinopathy in a rabbit model.
Yoshimura N; Kuriyama S; Ohuchi T; Takemura M; Honda Y; Hiraoka M
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):404-9. PubMed ID: 1740372
[TBL] [Abstract][Full Text] [Related]
2. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
Steinhorst UH; Chen EP; Hatchell DL; Samsa GP; Saloupis PT; Westendorf J; Machemer R
Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
Moritera T; Ogura Y; Yoshimura N; Honda Y; Wada R; Hyon SH; Ikada Y
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3125-30. PubMed ID: 1399416
[TBL] [Abstract][Full Text] [Related]
4. N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
Steinhorst UH; Chen EP; Machemer R; Hatchell DL
Exp Eye Res; 1993 Apr; 56(4):489-95. PubMed ID: 8500561
[TBL] [Abstract][Full Text] [Related]
5. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
Yang CM; Cousins SW
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341
[TBL] [Abstract][Full Text] [Related]
7. Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy.
Joondeph BC; Peyman GA; Khoobehi B; Yue BY
Ophthalmic Surg; 1988 Apr; 19(4):252-6. PubMed ID: 3362494
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
Kuriyama S; Ohuchi T; Okada M; Yamakawa R; Yoshimura N; Honda Y
Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
[TBL] [Abstract][Full Text] [Related]
9. Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes.
Assil KK; Hartzer M; Weinreb RN; Nehorayan M; Ward T; Blumenkranz M
Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2891-7. PubMed ID: 1917392
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-ricin A chain toxin limits the development of experimental proliferative vitreoretinopathy.
Handa JT; Keithahn MA; Jaffe GJ
Exp Eye Res; 1996 Jun; 62(6):689-96. PubMed ID: 8983950
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry.
Moorhead LC; Sepahban S; Armeniades CD
Ann Ophthalmol; 1991 Sep; 23(9):349-55. PubMed ID: 1741609
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy.
Araiz JJ; Refojo MF; Arroyo MH; Leong FL; Albert DM; Tolentino FI
Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):522-30. PubMed ID: 8449673
[TBL] [Abstract][Full Text] [Related]
14. Preretinal membrane formation in rabbit eyes after intravitreal transplantation of cultured astrocytes.
Mishima N; Yamashita H; Ishii Y; Hori S
Jpn J Ophthalmol; 1989; 33(4):501-18. PubMed ID: 2696800
[TBL] [Abstract][Full Text] [Related]
15. Heat effects on the retina.
Piyathaisere DV; Margalit E; Chen SJ; Shyu JS; D'Anna SA; Weiland JD; Grebe RR; Grebe L; Fujii G; Kim SY; Greenberg RJ; De Juan E; Humayun MS
Ophthalmic Surg Lasers Imaging; 2003; 34(2):114-20. PubMed ID: 12665226
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.
Kuriyama S; Ohuchi T; Yoshimura N; Honda Y; Hiraoka M; Abe M
Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):552-5. PubMed ID: 2265771
[TBL] [Abstract][Full Text] [Related]
17. A new model of proliferative vitreoretinopathy.
Frenzel EM; Neely KA; Walsh AW; Cameron JD; Gregerson DS
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2157-64. PubMed ID: 9761295
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies of proliferative vitreoretinopathy].
Kain HL
Fortschr Ophthalmol; 1991; 88(6):671-6. PubMed ID: 1794788
[TBL] [Abstract][Full Text] [Related]
19. Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies.
Akiyama H; Kachi S; Silva RL; Umeda N; Hackett SF; McCauley D; McCauley T; Zoltoski A; Epstein DM; Campochiaro PA
J Cell Physiol; 2006 May; 207(2):407-12. PubMed ID: 16419035
[TBL] [Abstract][Full Text] [Related]
20. Effect of adriamycin on experimental proliferative vitreoretinopathy in the rabbit.
Sunalp MA; Wiedemann P; Sorgente N; Ryan SJ
Exp Eye Res; 1985 Jul; 41(1):105-15. PubMed ID: 4029281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
